• Immunofluorescence analysis of NIH/3T3 cells, using SERC2 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Western blot analysis of lysates from HeLa cells, using SERC2 Antibody. The lane on the right is blocked with the synthesized peptide.
  • Western blot analysis of various cells using TDE2L Polyclonal Antibody

Anti-SERINC2 antibody (341-390 aa) (STJ95957)

SKU:
STJ95957

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Serine incorporator 2 (341-390 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:40000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SERINC2
Gene ID: 347735
Uniprot ID: SERC2_HUMAN
Immunogen Region: 341-390 aa
Specificity: TDE2L Polyclonal Antibody detects endogenous levels of TDE2L protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human SERC2 at the amino acid range 341-390
Database Links Reactome: R-HSA-977347
Cellular Localisation Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Serine Incorporator 2 antibody
Anti-Tumor Differentially Expressed Protein 2-Like antibody
Anti-SERINC2 antibody
Anti-TDE2L antibody
Anti-FKSG84 antibody
Anti-UNQ263 antibody
Anti-PRO300 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance